Search
for
Sort by
Research 211–240 of 1000+
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Janus kinase inhibitors for alopecia areata: A narrative review
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Tofacitinib for the treatment of lichen planopilaris: A case series
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Treatment of severe alopecia areata with baricitinib
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease